185 related articles for article (PubMed ID: 15302850)
1. Characterization of dendritic-like cells derived from t(9;22) acute lymphoblastic leukemia blasts.
Lee J; Sait SN; Wetzler M
Int Immunol; 2004 Oct; 16(10):1377-89. PubMed ID: 15302850
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of dendritic cell markers by all-trans retinoic acid on human acute promyelocytic leukemic cell line.
Park HY; Park JY; Kim JW; Lee MJ; Jang MJ; Lee SY; Baek DW; Park YM; Lee SW; Yoon S; Bae YS; Kwak JY
Int Immunopharmacol; 2004 Dec; 4(13):1587-601. PubMed ID: 15454112
[TBL] [Abstract][Full Text] [Related]
3. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
[TBL] [Abstract][Full Text] [Related]
4. The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patients.
Zou GM; Martinson J; Hu WY; Tam Y; Klingemann HG
Cancer Immunol Immunother; 2004 Aug; 53(8):681-9. PubMed ID: 15103504
[TBL] [Abstract][Full Text] [Related]
5. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy.
Choi BH; Kang HK; Park JS; Kim SK; Pham TN; Zhu XW; Cho D; Nam JH; Chung IJ; Kim YJ; Rhee JH; Kim HJ; Lee JJ
J Clin Apher; 2006 Dec; 21(4):233-40. PubMed ID: 17120232
[TBL] [Abstract][Full Text] [Related]
6. Human acute lymphoblastic leukemia (ALL) blasts as accessory cells during T-cell activation: differences between patients in costimulatory capacity affect proliferative responsiveness and cytokine release by activated T cells.
Bruserud O; Ulvestad E
Cancer Immunol Immunother; 2003 Apr; 52(4):215-25. PubMed ID: 12669246
[TBL] [Abstract][Full Text] [Related]
7. Direct contact of platelets and their released products exert different effects on human dendritic cell maturation.
Hamzeh-Cognasse H; Cognasse F; Palle S; Chavarin P; Olivier T; Delézay O; Pozzetto B; Garraud O
BMC Immunol; 2008 Sep; 9():54. PubMed ID: 18817542
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
Li L; Schmitt A; Reinhardt P; Greiner J; Ringhoffer M; Vaida B; Bommer M; Vollmer M; Wiesneth M; Döhner H; Schmitt M
Cancer Immun; 2003 Jul; 3():8. PubMed ID: 12862419
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins.
Moldenhauer A; Frank RC; Pinilla-Ibarz J; Holland G; Boccuni P; Scheinberg DA; Salama A; Seeger K; Moore MA; Nimer SD
J Leukoc Biol; 2004 Sep; 76(3):623-33. PubMed ID: 15197237
[TBL] [Abstract][Full Text] [Related]
10. T-Cell activation by t(9;22) acute lymphoblastic leukemia-derived dendritic-like cells is associated with increased tapasin expression.
Claus JA; Brady MT; Lee J; Donohue KA; Sait SN; Ferrone S; Wetzler M
Cancer Immunol Immunother; 2006 Feb; 55(2):160-5. PubMed ID: 16010586
[TBL] [Abstract][Full Text] [Related]
11. Synovial fluid transforming growth factor beta inhibits dendritic cell-T lymphocyte interactions in patients with chronic arthritis.
Summers KL; O'Donnell JL; Heiser A; Highton J; Hart DN
Arthritis Rheum; 1999 Mar; 42(3):507-18. PubMed ID: 10088774
[TBL] [Abstract][Full Text] [Related]
12. Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells.
Köhler T; Plettig R; Wetzstein W; Schmitz M; Ritter M; Mohr B; Schaekel U; Ehninger G; Bornhäuser M
Stem Cells; 2000; 18(2):139-47. PubMed ID: 10742386
[TBL] [Abstract][Full Text] [Related]
13. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
[TBL] [Abstract][Full Text] [Related]
14. Human epidermal Langerhans cells differ from monocyte-derived Langerhans cells in CD80 expression and in secretion of IL-12 after CD40 cross-linking.
Peiser M; Wanner R; Kolde G
J Leukoc Biol; 2004 Sep; 76(3):616-22. PubMed ID: 15178702
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
[TBL] [Abstract][Full Text] [Related]
16. Human monocyte-derived dendritic cells pulsed with wild-type p53 protein efficiently induce CTLs against p53 overexpressing human cancer cells.
Tokunaga N; Murakami T; Endo Y; Nishizaki M; Kagawa S; Tanaka N; Fujiwara T
Clin Cancer Res; 2005 Feb; 11(3):1312-8. PubMed ID: 15709203
[TBL] [Abstract][Full Text] [Related]
17. Anti-P-selectin lectin-EGF domain monoclonal antibody inhibits the maturation of human immature dendritic cells.
Zhou T; Zhang Y; Sun G; Zhang Y; Zhang D; Zhao Y; Chen N
Exp Mol Pathol; 2006 Apr; 80(2):171-6. PubMed ID: 16413535
[TBL] [Abstract][Full Text] [Related]
18. Monocyte-derived dendritic cells from HLA-matched allogeneic donors showed a greater ability to induce leukemic cell-specific T cells in comparison to leukemic cell-derived dendritic cells or monocyte-derived dendritic cells from AML patients.
Lee JJ; Choi BH; Kang HK; Kim SK; Nam JH; Yang DH; Kim YK; Kim HJ; Chung IJ
Leuk Res; 2008 Nov; 32(11):1653-60. PubMed ID: 18501426
[TBL] [Abstract][Full Text] [Related]
19. T-cadinol and calamenene induce dendritic cells from human monocytes and drive Th1 polarization.
Takei M; Umeyama A; Arihara S
Eur J Pharmacol; 2006 May; 537(1-3):190-9. PubMed ID: 16631732
[TBL] [Abstract][Full Text] [Related]
20. Costimulatory effects of T cell proliferation during infection with human T lymphotropic virus types I and II are mediated through CD80 and CD86 ligands.
Lal RB; Rudolph DL; Dezzutti CS; Linsley PS; Prince HE
J Immunol; 1996 Aug; 157(3):1288-96. PubMed ID: 8757637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
